on tirzepatide and still hungry Why am I tirzepatide? Common causes explained I'M NOT HUNGRY ANYMORE —
Description
Initiation rates for AOM GLP-1 RA increased substantially in March 2024, relative to December 2023 (+41.41%)
Example in development - Triple agonists targeting GLP-1, GIP, and glucagon are in early trials
Heimbrger SM, Bergmann NC, Augustin R, Gasbjerg LS, Christensen MB, Knop FK
Under such pressure, Novo Nordisk needs to achieve a new breakthrough in oral Semaglutide tablets to break this deadlock
Higher doses (Wegovy) are approved as a weight loss medicine
